NCT06409377View on ClinicalTrials.gov

Effect of Dexmedetomidine on Improving Intubating Conditions Without the Use of Muscle Relaxant

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

February 25, 2024

Primary Completion Date

April 30, 2024

Study Completion Date

May 2, 2024

Conditions
IntubationMuscle RelaxationDexmedetomidine
Interventions
DRUG

Precedex 200 MCG in 2 ML Injection

Patients received dexmedetomidine (1.5 μg/kg) as single injection over 10 minutes.

OTHER

C group:

Patients received propofol (2 mg/kg), fentanyl (1 μg/kg), and atracurium (0.5 mg/kg).

Trial Locations (2)

020

Theodor Bilharz research institute, Cairo

02

Theodor Bilharz research institute, Cairo

All Listed Sponsors
lead

Theodor Bilharz Research Institute

OTHER

NCT06409377 - Effect of Dexmedetomidine on Improving Intubating Conditions Without the Use of Muscle Relaxant | Biotech Hunter | Biotech Hunter